**Core Concept**
Syphilis, a chronic bacterial infection caused by *Treponema pallidum*, requires monitoring of cerebrospinal fluid (CSF) parameters during treatment, particularly in patients with neurosyphilis. The CSF examination helps in assessing the effectiveness of treatment and detecting potential complications.

**Why the Correct Answer is Right**
The most useful test in monitoring treatment in patients with neurosyphilis is the Venereal Disease Research Laboratory (VDRL) test in CSF. The VDRL test measures the level of antibodies against *Treponema pallidum* in the CSF. A decrease in VDRL titers after treatment initiation indicates a positive response to therapy. The CSF VDRL test is more sensitive than the serum VDRL test in detecting changes in CSF parameters during treatment.

**Why Each Wrong Option is Incorrect**
* **Option A:** The CSF protein level is not the most useful parameter in monitoring treatment in patients with neurosyphilis. While changes in CSF protein levels may occur during treatment, they are not as reliable as VDRL titers in assessing treatment response.
* **Option B:** The CSF cell count may not always correlate with the effectiveness of treatment in patients with neurosyphilis. A decrease in CSF cell count may not necessarily indicate a positive response to therapy.
* **Option C:** The CSF glucose level is not a reliable parameter in monitoring treatment in patients with neurosyphilis. Changes in CSF glucose levels may not necessarily indicate a positive response to therapy.

**Clinical Pearl / High-Yield Fact**
The CSF VDRL test is a critical parameter in monitoring treatment in patients with neurosyphilis. A decrease in CSF VDRL titers after treatment initiation is a strong indicator of a positive response to therapy.

**Correct Answer:** C. CSF VDRL test